Equiparin 50,000 IU/100 g gel for horses

País: Irlanda

Idioma: inglés

Fuente: HPRA (Health Products Regulatory Authority)

Ingredientes activos:

Heparin sodium ; Hydroxyethyl Salicylate ; Levomenthol

Disponible desde:

aniMedica GmbH

Código ATC:

QM02AC99

Designación común internacional (DCI):

Heparin sodium ; Hydroxyethyl Salicylate ; Levomenthol

Dosis:

50,000 IU/100g

formulario farmacéutico:

Gel

tipo de receta:

POM: Prescription Only Medicine as defined in relevant national legislation

Grupo terapéutico:

Horses

Área terapéutica:

preparations with salicylic acid derivatives, combinations

indicaciones terapéuticas:

Miscellaneous

Estado de Autorización:

Authorised

Fecha de autorización:

2010-01-24

Ficha técnica

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Equiparin 50.000 IU/100 g gel for horses.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
100 g gel contain:
ACTIVE SUBSTANCES:
Heparin sodium
50 000 I.U.
Hydroxyethyl salicylate
5.0 g
Levomenthol
0.5 g
EXCIPIENT(S):
Chlorophyllin copper (E 141)
0.004 g
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Gel.
Clear green cutaneous gel.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Horses.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of local inflammatory swellings and bruising,
including tendonitis, tenosynovitis, bursitis and other
acute inflammatory conditions of the musculo-skeletal system in the
horse.
Equiparin also promotes the early reabsorption of haematoma and
oedematous swelling resulting from such conditions.
4.3 CONTRAINDICATIONS
Do not use in case of hypersensitivity to the active substances or to
any of the excipients.
Not permitted for use in mares producing milk for human consumption.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_0_
_4_
_/_
_1_
_2_
_/_
_2_
_0_
_1_
_4_
_C_
_R_
_N_
_ _
_7_
_0_
_1_
_9_
_2_
_9_
_3_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Avoid contact with the eyes.
Do not apply to open wounds.
Do not apply to mucous membranes or skin lesions.
Discontinue if side effects such as signs of discomfort or